Health Care

Divi’s Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Conference Call Transcript

● Feb 11, 2022

Divi’s Laboratories Ltd (NSE: DIVISLAB) Q3 FY22 Earnings Concall dated Feb. 11, 2022 Corporate Participants: M. Satish Choudhury — Company Secretary and...

Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Transcript

● Feb 11, 2022

Piramal Enterprises Ltd (NSE : PEL) Q3 FY22 Earnings Concall dated  Feb. 10, 2022, Corporate Participants: Hitesh Dhaddha — Chief...

Dr Lal PathLabs Ltd Q3 FY22 Earnings Conference Call Insights

● Feb 11, 2022

Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY22 Earnings Concall Management Update: The company is enhancing access of...

Piramal Enterprises Ltd Q3 FY22 Earnings Conference Call Insights

● Feb 11, 2022

Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Management Update: In financial service, PEL said it plans...

Aurobindo Pharma Limited (AUROPHARMA) Q3 FY22 Earnings Concall Transcript

● Feb 10, 2022

Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra — Investor Relations Department...

Cadila Healthcare Ltd (CADILAHC) Q3 FY22 Earnings Concall Transcript

● Feb 3, 2022

Cadila Healthcare Limited  (NSE:CADILAHC) Q3 FY22 Earnings Concall dated Feb. 03, 2022 Corporate Participants: Ganesh Nayak — Executive Sharvil P....

IPO Alert: Rainbow Children’s Medicare Limited files for initial public offering

● Feb 3, 2022

The estimated size of the hospital market in India was ₹4,270 billion in the fiscal year 2020, representing an annual...

Jubilant Ingrevia Ltd Q3 FY22 Earnings Conference Call Insights

● Feb 2, 2022

Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY22 Earnings Concall Management Update: JUBLINGREA commented that with its capex plans...

Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q3 FY22 Earnings Concall Transcript

● Jan 31, 2022

Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY22 Earnings Concall dated Jan. 31, 2022 Corporate Participants: Nimish Desai — Head of Investor...

Infographic: Key highlights from Sun Pharma Q3 2022 earnings results

● Jan 31, 2022

Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a...